- CA$300.17m
- CA$252.95m
- $16.10m
Brief: Profound Medical Reports Results From Trial Of Tulsa-Pro For Prostate Cancer
Brief: Profound Medical Announces Fourth Quarter And Full Year 2018 Financial Results
Brief: Profound Medical Corp QTRLY Earnings Per Share $0.05
Brief: 3-Year Clinical Outcomes And Bph Subgroup Analysis Of Profound Medical’S Phase I Clinical Trial To Be Included In Presentation At Dgu 2018
Brief: Profound Medical Files Preliminary Base Shelf Prospectus
Canada Research Roundup: Cronos Group, Stella-Jones, Westshore Terminals Investment
Brief: Profound Medical Announces Term Loan Agreement With CIBC Innovation Banking
Canada Research Roundup: Manulife Financial, Mav Beauty Brands, Profound Medical, Suncor Energy
Brief: Profound Medical Corp Reports Q1 Earnings Per Share $0.06
Brief: Profound Medical Announces Chinese FDA Approval For Sonalleve
Canada Research Roundup: Orezone Gold, Profound Medical, Roxgold
Brief: Profound Medical Corp Reports Q4 Loss Per Share Of $0.06
Canada Research Roundup: Alimentation Couche Tard, Integra Resources, Profound Medical
Brief: Profound Medical Corp Upsizes Previously Announced Bought Deal Financing
Brief: Profound Medical Announces $20 Mln Bought Deal Financing
Brief: Profound Medical Announces Preliminary Q4 Revenue
Brief: Profound Medical Corp reports qtrly loss per share $0.09
Brief: Profound Medical Corp announces $10 mln "bought deal" financing
Brief: Profound Medical Q2 loss per share C$0.08